Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH)
NCT ID: NCT01752725
Last Updated: 2012-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2011-10-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BiCision Arm
Coagulation with BiCision
BiCision®
Ultracision Arm
Coagulation with Ultracision
Ultracision® Har-monic Scalpel(Ethicon)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BiCision®
Ultracision® Har-monic Scalpel(Ethicon)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gender: female
* indication for laparoscopic supracervical hysterectomy with no adnexectomyor other surgery
* will and the capability to comply the study requirements
* signed informed consent
Exclusion Criteria
* Cardiac pacemaker or implanted defibrilator if no informations are available about the compatibil-ity with RF energy
* Abnormal blood parameters (values less than factor 0.8 or more than 1.25 compared to the val-ues of creatinine and standard hemogram)
* Inability to understand the purpose of the study
* status after a laparotomy by a longitudinal incision
* intraabdominal adhesions (at the beginning of the surgery ≥ 5 sectioning for adhesiolysis)
* open laparoscopy required
* different anatomical situations that yields to different surgery requirements
* conspicuous PAP, cervixmyoma or endometriosis of the rectovaginale space
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erbe Elektromedizin GmbH
INDUSTRY
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernhard Kraemer
Executive / Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diethelm Wallwiener, Professor
Role: STUDY_CHAIR
University Hospital Tuebingen
Bernhard Krämer, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04122012
Identifier Type: -
Identifier Source: org_study_id